RecruitingNot ApplicableNCT06600347

Effect of DASH Diet and Progressive Muscle Relaxation on Cardiovascular Risks in Postmenopausal Women


Sponsor

Cairo University

Enrollment

90 participants

Start Date

Jun 10, 2024

Study Type

INTERVENTIONAL

Conditions

Summary

This study will be conducted to investigate the effect of DASH diet and Progressive muscle relaxation on cardiovascular risks in postmenopausal women.


Eligibility

Sex: FEMALEMin Age: 50 YearsMax Age: 60 Years

Plain Language Summary

Simplified for easier understanding

This clinical trial is studying Anti hypertensive drugs, DASH diet, and others for people with cardiovascular complication. The study is currently recruiting participants at 1 location. People eligible for this study include women aged 50 Years to 60 Years.

This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.

Interested in this trial?

Get notified about updates and connect with the research team.

Interventions

DIETARY_SUPPLEMENTDASH diet

The participants will be treated with the DASH diet (1600-1800 calories/ day) for three months, in addition to antihypertensive drugs.

OTHERProgressive muscle relaxation

The participants will be treated with progressive muscle relaxation for 30 minutes, 3 times/week for 3 months, in addition to antihypertensive drugs.

DRUGAnti hypertensive drugs

All participants in all groups will be treated with antihypertensive drugs as prescribed from the physician


Locations(1)

Farahnaz Ahmed Mohamed

Suez, Egypt

View Full Details on ClinicalTrials.gov

For the most up-to-date information, visit the official listing.

Visit

NCT06600347


Related Trials